瘤内在的P2RY6通过增强PGE2生产驱动免疫抑制
Xilong Xu1, Yi Lu2, Longzhi Cao3
1College of Life Sciences, Beijing Normal University, Beijing 100875, China; National Institute of Biological Sciences, Beijing 102206, China.
在瘤中异常的P2RY6表达驱动免疫逃避和免疫疗法抵抗. 向这种pyrimidinergic受体可以克服癌症患者的治疗不响应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 反编程细胞死亡-1 (anti-PD-1) 免疫疗法显示出希望,但面临的挑战是患者不响应和缺乏预测生物标志物.
- 确定新的点对于提高癌症治疗疗效至关重要.
研究的目的:
- 研究胺基受体P2RY6在癌症免疫逃避和免疫治疗耐药性中的作用.
- 探索P2RY6作为增强抗PD-1疗效的潜在治疗标.
主要方法:
- 在人类癌症中分析P2RY6表达.
- 利用小鼠同源和人类异源移植瘤模型来评估P2RY6功能.
- 研究了下游的信号通路,包括Gq/脂酶C-β和前列腺素E2合成.
主要成果:
- 异常的P2RY6表达在人类癌症中很常见,并促进免疫逃避.
- 异位P2RY6表达通过创建免疫抑制瘤微环境 (TME) 来增强瘤生长和免疫治疗耐药性.
- 高表达瘤中的P2RY6删除逆转免疫抑制,通过前列腺素E2信号抑制瘤生长.
结论:
- P2RY6是瘤诱导免疫抑制和抗PD-1疗法耐药性的关键驱动因素.
- 向瘤内在的P2RY6代表了在特定癌症患者群体中精确免疫治疗的有希望的策略.
- 在小鼠中的全球P2ry6删除不会影响活力,这表明针对瘤中的P2RY6的安全性概况有利.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
14:15Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS
Published on: June 18, 2012
相关概念视频
Abnormal Proliferation
Tumor Immunotherapy
The Tumor Microenvironment
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
